Heterogeneity of 68Ga-FAPI Uptake As Imaging Biomarker in T-DXd Treatment for Brain Metastasis of HER2 Positive Breast Cancer

NCT06797622 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Metastatic Breast Cancer

Interventions

DRUG: Trastuzumab deruxtecan (T-DXd)

Sponsor

Fudan University